Chapter 57 – Pulmonary Vasodilators

[1]  N. Voelkel,et al.  Hypoxia-induced pulmonary vascular remodeling: a model for what human disease? , 2000, The Journal of clinical investigation.

[2]  L. Rubin,et al.  Primary pulmonary hypertension. , 1997, The New England journal of medicine.

[3]  M. Juhaszova,et al.  Hypoxia inhibits gene expression of voltage-gated K+ channel alpha subunits in pulmonary artery smooth muscle cells. , 1997, The Journal of clinical investigation.

[4]  J. Barberà,et al.  Nitric oxide inhalation during exercise in chronic obstructive pulmonary disease. , 1997, American journal of respiratory and critical care medicine.

[5]  P. Wagner,et al.  Effects of inhaled nitric oxide on gas exchange in lungs with shunt or poorly ventilated areas. , 1997, American journal of respiratory and critical care medicine.

[6]  M. Yoshida,et al.  Combined inhalation of nitric oxide and oxygen in chronic obstructive pulmonary disease. , 1997, American journal of respiratory and critical care medicine.

[7]  L. Rubin.  The renin-angiotensin system and the "lesser circulation". A role in cor pulmonale? , 1996, Chest.

[8]  J. Barberà,et al.  Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease , 1996, The Lancet.

[9]  Y. Castaing,et al.  Effect of inhaled nitric oxide on hemodynamics and VA/Q inequalities in patients with chronic obstructive pulmonary disease. , 1994, American journal of respiratory and critical care medicine.

[10]  S. Adnot,et al.  Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension. , 1993, The American review of respiratory disease.

[11]  P. Frith,et al.  Felodipine improves pulmonary hemodynamics in chronic obstructive pulmonary disease. , 1993, Chest.

[12]  R. Rossaint,et al.  Inhaled nitric oxide for the adult respiratory distress syndrome. , 1993, The New England journal of medicine.

[13]  G. Domenighetti,et al.  Short- and long-term hemodynamic effects of oral nifedipine in patients with pulmonary hypertension secondary to COPD and lung fibrosis. Deleterious effects in patients with restrictive disease. , 1992, Chest.

[14]  D. Magometschnigg,et al.  Differential therapy with calcium antagonists in pulmonary hypertension secondary to COPD. Hemodynamic effects of nifedipine, diltiazem, and verapamil. , 1990, Chest.

[15]  L. Rubin,et al.  Effects of nitrendipine and hypoxia on pulmonary vascular resistance in experimental emphysema. , 1990, The American review of respiratory disease.

[16]  P. Agostoni,et al.  Nifedipine reduces pulmonary pressure and vascular tone during short- but not long-term treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease. , 1989, The American review of respiratory disease.

[17]  P. Surpas,et al.  One-year clinical study on nifedipine in the treatment of pulmonary hypertension in chronic obstructive lung disease. , 1988, Respiration; international review of thoracic diseases.

[18]  O. Burghuber.  Nifedipine attenuates acute hypoxic pulmonary vasoconstriction in patients with chronic obstructive pulmonary disease. , 1987, Respiration; international review of thoracic diseases.

[19]  F. Khaja,et al.  Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. , 1985, Annals of internal medicine.

[20]  E. K. Weir,et al.  Comparative effects of nifedipine, verapamil, and diltiazem on experimental pulmonary hypertension. , 1983, The American journal of cardiology.